Folio 05 Insights Article

Licensing guides

What transfers with a licensed entity - and what does not

In a share purchase, the company changes hands with everything inside it: the licence or registration (subject to a change-of-control process), the compliance file and policies, the full regulatory history and the tax history - good and bad. What does not carry over automatically matters just as much: bank and PSP relationships, key personnel and approved officers, contracts with change-of-control clauses, and the seller's personal regulatory approvals. Price the deal on the first list, and have a plan for the second before you sign.

Continuity

Why a share purchase changes the question

When you buy a licensed company, you are almost always buying its shares, not its assets. The legal person continues uninterrupted: nothing inside the company has to move, because the company itself is what moves. Contracts stay in its name, the registration stays on the regulator's books, and the filing history stays exactly where it was.

That continuity is the whole appeal of buying an existing licensed company rather than applying from scratch - and it is also where buyers misjudge deals. The real question is not what the company owns today, but which of those things survive contact with a new owner. The licence itself does, subject to the regulator approving you as the incoming owner; we walk through that approval step in our guide to change of control.

In a share purchase

Transfers with the entity

  • The licence or registration

    It stays with the company - subject to the regulator's change-of-control process, which approves you as the new owner rather than re-issuing the permission.

  • The compliance file and policies

    The AML programme, procedures, manuals and registers - the documented framework the licence was granted against - come with the entity.

  • The regulatory history

    Including any past findings. The supervisory record belongs to the company, not to the outgoing owner.

  • Contracts in the company name

    Client agreements, vendor contracts and leases held by the entity continue - unless a clause inside them says otherwise.

  • The tax history - good and bad

    Filed returns, positions taken, and any exposure sitting under them all remain with the legal person you now own.

Plan for these

Does not transfer automatically

  • Bank and PSP relationships

    Banks re-run KYC on the new UBOs and can choose to exit. Treat every account as conditional until it has been re-confirmed under your ownership.

  • Key personnel and approved officers

    People are not assets. If the compliance officer or approved directors leave - or you replace them - the successors may need regulator approval before they can act.

  • Contracts with change-of-control clauses

    A counterparty whose contract contains a change-of-control clause may need to consent to the new ownership. Assume the important counterparties will read the clause.

  • The seller's personal regulatory approvals

    Approvals attached to the seller as an individual stay with the seller. They do not pass to you or your team.

Banking

The bank account misconception

The most expensive assumption in this market is that the operating accounts come with the company. They sit in the company's name, so on paper they continue - but banking is a relationship, not an asset, and the relationship is with the people behind the company as much as with the company itself.

When ownership changes, banks re-run KYC on the new UBOs. They can ask for the same file a fresh applicant would provide, and they can decide to exit the relationship altogether. The same logic applies to PSPs. None of this means the accounts will close - but whether they stay open is the bank's decision, not a term of your share purchase agreement.

So the rule we give every buyer: never price a deal assuming the accounts survive. Model the acquisition as if you will re-establish banking, open the conversation with the incumbent bank early, and treat any account that continues under your ownership as upside rather than a dependency.

The transfer map

What carries over - and on what condition

What Carries over in a share purchase? What to plan for
What Licence or registration Carries over in a share purchase? Yes What to plan for Change-of-control approval of the new owner
What Compliance file and AML programme Carries over in a share purchase? Yes, on paper What to plan for Re-approval and a refit to your actual transaction flow
What Regulatory and tax history Carries over in a share purchase? Yes - good and bad What to plan for Diligence on pending examinations, findings and exposure
What Contracts in the company name Carries over in a share purchase? Yes, unless a clause says otherwise What to plan for Change-of-control clauses may require counterparty consent
What Bank and PSP relationships Carries over in a share purchase? No What to plan for Re-KYC of the new UBOs; the bank can exit
What Key personnel and approved officers Carries over in a share purchase? No What to plan for Replacements may need regulator approval
What Seller's personal regulatory approvals Carries over in a share purchase? No What to plan for They stay with the seller

Due diligence

The liabilities travel with the shares

Continuity cuts both ways. Because the legal person survives the sale intact, so does everything filed, found and left unfinished under the previous owner. Inherited liabilities in a share purchase include pending regulator examinations, unremediated AML findings and undisclosed tax exposure - none of which reset when the shares change hands.

This is why due diligence on a regulated entity goes beyond standard corporate DD. Reviewing the accounts and the contracts tells you what the company owns; only reading the supervisory correspondence, the compliance registers and the tax file tells you what it owes. In our process, the regulatory file is a primary diligence object, not an appendix to the financial review.

The refit

Policies transfer on paper - the fit does not

The compliance manual, the AML programme, the risk assessments: all of it comes with the entity, and all of it was written for someone else's business. Policies and AML programmes transfer on paper but must be re-approved and refitted to the new owner's actual transaction flow before they describe the business you intend to run.

If the seller ran low-volume corporate payments and you plan higher-volume retail flows, the inherited programme documents a company you do not operate. Budget the refit as real post-completion work: an updated risk assessment, recalibrated monitoring, and re-approval of the framework under your ownership.

FAQ

Frequently asked questions

Straight answers to what founders and buyers ask. If yours isn't here, ask us directly

01 Do the bank accounts survive the ownership change?

Not automatically. Banks re-run KYC on the new UBOs and can exit the relationship, and the same applies to PSPs. Never price a deal on the assumption that the accounts survive - treat banking continuity as something to be re-confirmed under your ownership, not inherited with the shares.

02 Do I inherit the seller's past AML violations?

In a share purchase, the regulatory history - including past findings - stays with the company you now own. Inherited liabilities can include pending regulator examinations, unremediated AML findings and undisclosed tax exposure, which is why diligence on a regulated entity goes beyond standard corporate DD.

03 Can key staff leave after the sale?

Yes. Key personnel and approved officers do not transfer automatically with the shares, and replacements may need regulator approval before they can take up the role. Build retention and succession into the deal rather than assuming the team stays.

Tell us what you need

Price the deal on what actually transfers

SKY7 due diligence separates what the entity carries from what you will rebuild - before you commit.

Editorial note

Editorial disclaimer

Reviewed by Sofia Reinholt. Last reviewed: 10 July 2026. This article is general information only, not legal, regulatory, tax, investment or financial advice.